Avivo, a British Columbia-based preclinical-stage company, has identified enzymes that convert the cell surface antigens that determine a person’s blood group to group O, the universal donor type. This innovative platform enables a world where a person’s blood type is no longer the first constraint when they need life-saving organ transplants or blood transfusions. Avivo’s platform will enable healthcare providers to better prioritize patients by medical urgency, spend less on management and logistics and ultimately save more lives.
Company Details
- Employees
- 16
- Founded
- -
- Address
- Vancouver, British Columbia, Ca
- Industry
- Biotechnology
- Website
- abozymes.com
- Keywords
- enzymes, blood transfusion, organ transplantation, universal donor blood, universal donor organs.
- HQ
- Vancouver, British Columbia
Avivo Biomedical Inc. Questions
Avivo Biomedical Inc.'s website is abozymes.com
Avivo Biomedical Inc.'s LinkedIn profile is https://ca.linkedin.com/company/avivobio
Avivo Biomedical Inc. has
16 employees.
View email and phone details for 16
employees at Avivo Biomedical Inc..
Avivo Biomedical Inc.'s industry is
Biotechnology
Avivo Biomedical Inc.'s top competitors are
Avivo,
Probius,
Rapidemic,
Breathe Biomedical Inc.,
Borealis Biosciences, Inc.,
Notogen Inc.,
Avivo,
Cerecura Nanotherapeutics,
Aspect Biosystems,
Pulmonem Inc..
Avivo Biomedical Inc.'s categories are Biotechnology
Avivo Biomedical Inc.'s founding year is 2020
